130 related articles for article (PubMed ID: 28111273)
1. Serum and urinary thioredoxin concentrations are associated with severity of children hydronephrosis.
Xu ZM; Li MJ; Tao C
Clin Chim Acta; 2017 Mar; 466():127-132. PubMed ID: 28111273
[TBL] [Abstract][Full Text] [Related]
2. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
Alizadeh F; Taefnia AM; Haghdani S
J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
4. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
[TBL] [Abstract][Full Text] [Related]
5. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
[TBL] [Abstract][Full Text] [Related]
6. Urinary cytokine profiles in unilateral congenital hydronephrosis.
Taranta-Janusz K; Wasilewska A; Dębek W; Waszkiewicz-Stojda M
Pediatr Nephrol; 2012 Nov; 27(11):2107-2113. PubMed ID: 22744767
[TBL] [Abstract][Full Text] [Related]
7. Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstruction.
Li Z; Liu X; Liu S; Gu C; Tian F; Wen J
Biomarkers; 2012 Aug; 17(5):471-6. PubMed ID: 22630328
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin-3A and Netrin-1 predict the development of kidney injury in children with congenital hydronephrosis.
Li X; Liu X; Li J; Song E; Sun N; Liu W; Wang T; Yang J; Li Z
Scand J Clin Lab Invest; 2018; 78(1-2):55-61. PubMed ID: 29199452
[TBL] [Abstract][Full Text] [Related]
9. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.
Taranta-Janusz K; Wasilewska A; Dębek W; Fiłonowicz R; Michaluk-Skutnik J
Acta Paediatr; 2013 Sep; 102(9):e429-33. PubMed ID: 23772991
[TBL] [Abstract][Full Text] [Related]
10. Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children.
Mello MF; Thalita Dos Reis S; Kondo EY; de Bessa Júnior J; Dénes FT; Lopes RI
J Pediatr Urol; 2021 Aug; 17(4):438.e1-438.e7. PubMed ID: 33863647
[TBL] [Abstract][Full Text] [Related]
11. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.
Atar A; Oktar T; Kucukgergin C; Kalelioglu I; Seckin S; Ander H; Ziylan O; Kadioglu TC
J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
[TBL] [Abstract][Full Text] [Related]
13. Potential Novel Biomarkers of Obstructive Nephropathy in Children with Hydronephrosis.
Bieniaś B; Sikora P
Dis Markers; 2018; 2018():1015726. PubMed ID: 30327688
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up.
Chertin B; Pollack A; Koulikov D; Rabinowitz R; Hain D; Hadas-Halpren I; Farkas A
Eur Urol; 2006 Apr; 49(4):734-8. PubMed ID: 16504374
[TBL] [Abstract][Full Text] [Related]
15. Urinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment.
Tian F; Gu C; Zhao Z; Li L; Lu S; Li Z
Nephrology (Carlton); 2015 Mar; 20(3):194-200. PubMed ID: 25470073
[TBL] [Abstract][Full Text] [Related]
16. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
Assadi F; Mazaheri M
J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
[TBL] [Abstract][Full Text] [Related]
17. Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels.
Mohammadjafari H; Rafiei A; Kosaryan M; Yeganeh Y; Hosseinimehr SJ
Biomark Med; 2014; 8(10):1199-206. PubMed ID: 25525980
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage.
Dai JX; Cai JY; Lin Q; Chen XD; Lu C; Sun J; Ba HJ
J Neurol Sci; 2016 Apr; 363():84-9. PubMed ID: 27000227
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum thioredoxin concentrations after intracerebral hemorrhage.
Qian SQ; Hu XC; He SR; Li BB; Zheng XD; Pan GH
Clin Chim Acta; 2016 Apr; 455():15-9. PubMed ID: 26774697
[TBL] [Abstract][Full Text] [Related]
20. Urine exoglycosidases are potential markers of renal tubular injury in children with ureteropelvic junction obstruction.
Taranta-Janusz K; Zalewska-Szajda B; Chojnowska S; Wasilewska A
Acta Paediatr; 2015 Nov; 104(11):e518-23. PubMed ID: 26095925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
